clinical trial · NCT06793748
Study to Evaluate the Safety, Tolerability, and Efficacy of PEP-TISSEEL in Subjects With Chronic Radiation Ulcer
Chronic Radiation UlcerPEP-TISSEELTISSEEL Fibrin Sealant KITPEP-TISSEELTISSEEL Fibrin Sealant KIT
brief summary
The goal of this clinical trial is to learn if drug Purified Exosome Product (PEP™) and Fibrin Sealant (TISSEEL® VH SD Kit) (PEP-TISSEEL) works to treat chronic radiation ulcer in adults and compare it with comparator TISSEEL. It will also learn about the safety of drug PEP-TISSEEL.
started
Jun 1, 2025
primary completion
Nov 1, 2025
completion
Feb 1, 2026
last updated
Apr 6, 2025
official title
An Adaptive Two-Part, Phase 1/2, Multi-Center, Double-Blinded, Randomized, Controlled Study of the Safety and Efficacy of Topically Applied PEP-TISSEEL in Participants With Chronic Radiation Ulcer
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol